4 October 2023
Target Healthcare REIT plc and its subsidiaries
("Target Healthcare" or "the Group")
Notice of Full Year Results
Target Healthcare (LSE: THRL), the UK listed specialist investor in modern, purpose-built care homes, will announce its full year results for the twelve months ended 30 June 2023 on Tuesday, 10 October 2023.
An in-person presentation for analysts and investors will be held at 08.45 a.m. on the day of the results. The Company will also be hosting a live webcast.
For further information or to register your attendance, please get in touch with FTI Consulting at:
targethealthcare@fticonsulting.com.
Enquiries:
| | |
| | |
| Target Fund Managers: Kenneth MacKenzie Gordon Bland | Tel: +44 (0)1786 845 912
|
|
FTI Consulting: Dido Laurimore Richard Gotla |
Tel: +44 (0)20 3727 1000 |
| Talia Shirion | |
| | |
Notes:
UK listed Target Healthcare REIT plc (THRL) is an externally managed Real Estate Investment Trust which provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of modern, purpose-built care homes.
The Group's portfolio at 30 June 2023 comprised 97 assets let to 32 tenants with a total value of £868.7 million.
The Group invests in modern, purpose-built care homes that are let to high quality tenants who demonstrate strong operational capabilities and a strong care ethos. The Group builds collaborative, supportive relationships with each of its tenants as it believes working in this way helps raise standards of care and helps its tenants build sustainable businesses. In turn, that helps the Group deliver stable returns to its investors.
LEI: 213800RXPY9WULUSBC04
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
